Abnormal movements in Hong Kong stocks | Zhongyan Pharmaceuticals (06127.HK) dropped by over 8% in the afternoon, with only a slight year-on-year increase in revenue in the first half of the year. The main profit contribution comes from the higher prices of experimental monkeys.
According to the Securities Times app, Zhongyan New Drug (06127.HK) fell by more than 8% in the afternoon, and as of the time of submission, it had fallen by 4.22% to HK$26.32, with a turnover of HK$1.613 billion.
Latest
